# Inhibrx Biosciences, Inc. (INBX) vs State Street SPDR S&P 500 ETF Trust (SPY) · total-return overlay

LOPJLB holding-return compare (5Y). Dividends and splits. Each path starts at 0% from the first adjusted close in the window.

Inhibrx Biosciences, Inc. (INBX) vs State Street SPDR S&P 500 ETF Trust (SPY) total return over 5Y: INBX +131.39%, SPY +86.64%. Regime INBX CRISIS · SPY BULL. As of Oct 13, 2026. Research only.

- Interactive: https://www.lopjlb.com/vs/INBX/SPY
- API: `GET /bff/api/bigfive/compare-series?symbols=INBX%2CSPY&range=5y`

## Window

| Symbol | Window % | Worst drawdown | YTD |
|---|---:|---:|---:|
| INBX | +131.39% | -81.49% | +16.04% |
| SPY | +86.64% | -24.49% | +14.78% |

## Periods (calendar lookback)

| Symbol | 1Y | 2Y | 3Y | 5Y |
|---|---:|---:|---:|---:|
| INBX | +153.29% | +461.81% | +419.13% | +131.39% |
| SPY | +18.61% | +36.22% | +86.97% | +86.64% |

## Annual

| Year | INBX | SPY |
|---|---:|---:|
| YTD | +16.04% | +14.78% |
| 2025 | +418.03% | +18.01% |
| 2024 | -57.28% | +25.59% |
| 2023 | +63.09% | +26.73% |
| 2022 | -42.94% | -18.64% |
| 2021 | +9.97% | +6.90% |

---

Research context only. Not personalized investment advice.
